
HER2-Positive Gastrointestinal Cancers — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Oncology Today with Dr Neil Love
00:00
Treatment decisions for very elderly patients
Eric Van Cutsem and panel discuss supportive care versus HER2 targeted therapy in nonagenarian patients.
Play episode from 06:56
Transcript


